Sarah M. Ruttenberg

Sarah M. Ruttenberg

Auto-generated profile, based on publicly available information

Sarah M. Ruttenberg

Department of Chemistry, University of California, Irvine

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
AKAdam G. Kreutzer
Adam G. Kreutzer
GGGretchen Guaglianone
Gretchen Guaglianone
SYStan Yoo
Stan Yoo
CPChelsea Marie T. Parrocha
Chelsea Marie T. Parrocha
SRSarah M. Ruttenberg
Sarah M. Ruttenberg
JNJames S. Nowick
James S. Nowick
The assembly of the β-amyloid peptide (Aβ) to form oligomers and fibrils is closely associated with the pathogenesis and progression of Alzheimer’s disease. Aβ is a shape-shifting peptide capable of adopting many conformations and folds within the multitude of oligomers and fibrils the peptide forms. These properties have precluded detailed structural elucidation and biological characterization of homogeneous, well-defined Aβ oligomers. In this paper, we compare the structural, biophysical, and biological characteristics of two different covalently stabilized isomorphic trimers derived from the central and C -terminal regions Aβ. X-ray crystallography reveals the structures of the trimers and shows that each trimer forms a ball-shaped dodecamer. Solution-phase and cell-based studies demonstrate that the two trimers exhibit markedly different assembly and biological properties. One trimer forms small soluble oligomers that enter cells through endocytosis and activate capase-3/7-mediated apoptosis, while the other trimer forms large insoluble aggregates that accumulate on the outer plasma membrane and elicit cellular toxicity through an apoptosis-independent mechanism. The two trimers also exhibit different effects on the aggregation, toxicity, and cellular interaction of full-length Aβ, with one trimer showing a greater propensity to interact with Aβ than the other. The studies described in this paper indicate that the two trimers share structural, biophysical, and biological characteristics with oligomers of full-length Aβ. The varying structural, assembly, and biological characteristics of the two trimers provide a working model for how different Aβ trimers can assemble and lead to different biological effects, which may help shed light on the differences among Aβ oligomers.

21 May 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
SRSarah M. Ruttenberg
Sarah M. Ruttenberg
RDRakia Dhaoui
Rakia Dhaoui
AKAdam G. Kreutzer
Adam G. Kreutzer
JNJames S. Nowick
James S. Nowick
Anti-Aβ antibodies are important tools for identifying structural features of aggregates of the Aβ peptide and are used in many aspects of Alzheimer’s disease (AD) research. Our laboratory recently reported the generation of a polyclonal antibody, pAb 2AT-L , that is moderately selective for oligomeric Aβ over monomeric and fibrillar Aβ and recognizes the diffuse peripheries of Aβ plaques in AD brain tissue but does not recognize the dense fibrillar plaque cores. This antibody was generated against 2AT-L, a structurally defined Aβ oligomer mimic composed of three Aβ-derived β-hairpins arranged in a triangular fashion and covalently stabilized with three disulfide bonds. In the current study, we set out to determine if pAb 2AT-L is neuroprotective against toxic aggregates of Aβ and found that pAb 2AT-L protects human iPSC-derived neurons from Aβ 42 -mediated toxicity at molar ratios as low as 1:100 antibody to Aβ 42 , with a ratio of 1:25 almost completely rescuing cell viability. Few other antibodies have been reported to exhibit neuroprotective effects at such low ratios of antibody to Aβ. ThT and TEM studies indicate that pAb 2AT-L delays but does not completely inhibit Aβ 42 fibrillization at sub-stoichiometric ratios. The ability of pAb 2AT-L to inhibit Aβ 42 toxicity and aggregation at sub-stoichiometric ratios suggests that pAb 2AT-L binds toxic Aβ 42 oligomers and does not simply sequester monomeric Aβ 42 . These results further suggest that toxic oligomers of Aβ 42 share significant structural similarities with 2AT-L. TOC Graphic: